Liver-specific PhenoAgeAccel
1 paper3 findings
- Humans1
Effects
1Liver-related outcomes
mediatesin humans1
1 study
Liver-related outcomes
mediatesin humans1
Liver-specific PhenoAgeAccel mediates liver-related outcomes in humans (10-27%).
“Approximately 10-27% of the associations between risk behaviors and liver-related outcomes were mediated by liver-specific PhenoAgeAccel.”
Humansof the associations between risk behaviors and liver-related outcomes
Liver-specific phenotypic aging, behavior and genetic risks, and long-term liver-related outcomes
GeroScience28 Jan 2026
Associations
2Liver-related events
upin humans1
1 study
Liver-related events
upin humans1
Liver-specific PhenoAgeAccel raises the risk of liver-related events in humans (1.23- to 2.97-fold increased risks).
“Liver-specific PhenoAgeAccel was significantly associated with a 1.23- to 2.97-fold increased risks of all-cause mortality and liver-related events.”
Humans
Liver-specific phenotypic aging, behavior and genetic risks, and long-term liver-related outcomes
GeroScience28 Jan 2026
Mortality
upin humans1
1 study
Mortality
upin humans1
Liver-specific PhenoAgeAccel raises the risk of mortality in humans (1.23- to 2.97-fold increased risks).
“Liver-specific PhenoAgeAccel was significantly associated with a 1.23- to 2.97-fold increased risks of all-cause mortality and liver-related events.”
Humans
Liver-specific phenotypic aging, behavior and genetic risks, and long-term liver-related outcomes
GeroScience28 Jan 2026